Events

Subscribe to KUMC Events Calendar via Outlook

RSS RSS of Events

Information for:

Students
Faculty & Staff
Researchers
Patients
Prospective Employees
Alumni | Donors

Academics

ANGEL | JayDocs
The Beat
Enroll & Pay
Dykes Library
Academic Calendar
More Student Services

Email Outlook
myKUMC myKUMC
SharePoint SharePoint
HR/Pay HR/Payroll System

Patient Clinical Logging
Secure File Transfers
VPN

KUMC Leadership
Facilities & Maintenance
Human Resources
Information Resources

  1. KUMC A-Z:
  2. A
  3. B
  4. C
  5. D
  6. E
  7. F
  8. G
  9. H
  10. I
  11. J
  12. K
  13. L
  14. M
  15. N
  16. O
  17. P
  18. Q
  19. R
  20. S
  21. T
  22. U
  23. V
  24. W
  25. X
  26. Y
  27. Z
  28. all

National Institutes of Health

Doctors looking at xray

Together, the NIH Therapeutics for Rare and Neglected Diseases (TRND) program and IAMI are demonstrating a new way for government and academia to work together for a positive effect on patients' lives.

The TRND program is an effort to encourage and speed the development of new drugs for rare and neglected diseases.

This program is specifically intended to stimulate drug discovery and development research collaborations between NIH and academic scientists, nonprofit organizations, and pharmaceutical and biotechnology companies working on rare and neglected illnesses.

IAMI's approach is extremely complementary to the objectives of the program.

Last modified: May 22, 2012
About

NIH logoThe National Institutes of Health (NIH) is made up of 27 different components called Institutes and Centers. Each has its own specific research agenda. All but three of these components receive their funding directly from Congress and administrate their own budgets.

NIH's mission is to seek fundamental knowledge about the nature of behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability.

Learn more about NIH